Leishmania infantum enhances human immunodeficiency virus type-1 replication in primary human macrophages through a complex cytokine network

Clinical Immunology : the Official Journal of the Clinical Immunology Society
Chenqi ZhaoMichel J Tremblay

Abstract

Leishmaniasis has emerged as an important potential opportunistic disease among patients infected with human immunodeficiency virus type-1 (HIV-1). It has been reported that the visceral form of leishmaniasis accelerates the course of HIV-1 disease progression and shortens the life expectancy of persons in areas where both diseases are endemic. As both pathogens can infect in a productive manner the same target cell, that is, the macrophage, we examined the possible modulatory effect of the protozoan parasite Leishmania infantum on the biology of HIV-1 in primary human monocyte-derived macrophages (MDMs). We found that coinfection of MDMs with Leishmania and HIV-1 resulted in a significant enhancement of both virus transcription and release of progeny virus. The Leishmania-directed increase in HIV-1 production was associated with an increased secretion of the proinflammatory cytokines TNF-alpha and IL-1 alpha. Altogether, these findings indicate that the presence of Leishmania and HIV-1 within the same cellular microenvironment leads to an enhancement of virus gene expression. The present work also underscores the importance of studying the possible complex interactions between two human pathogens in a physiological cellular re...Continue Reading

Citations

Jul 9, 2010·The Lancet Infectious Diseases·Kayvon Modjarrad, Sten H Vermund
Oct 12, 2010·Clinical Microbiology Reviews·J L N BarrattD Stark
Apr 11, 2008·Clinical Microbiology Reviews·Jorge AlvarJavier Moreno
Dec 22, 2010·BMC Infectious Diseases·Joanna R Santos-OliveiraAlda M Da-Cruz
Sep 13, 2012·PLoS Neglected Tropical Diseases·Deivid Costa SoaresElvira M Saraiva
Jan 26, 2013·PLoS Neglected Tropical Diseases·Yegnasew TakelePascale Kropf
Aug 30, 2012·Journal of Visualized Experiments : JoVE·Guadalupe AndreaniDave Richard
May 29, 2007·Trends in Parasitology·Ravendra GargMichel J Tremblay
Jan 8, 2009·International Journal of Dermatology·Smeeta SinhaRobert A Schwartz
Dec 3, 2014·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Sarman Singh
Aug 22, 2014·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A VallejoJ L Casado
Jul 11, 2014·PLoS Neglected Tropical Diseases·Rebecca J FaleiroChristian R Engwerda
Jul 1, 2006·Expert Review of Clinical Immunology·Stephanie Venzke, Oliver T Keppler
Mar 16, 2012·Current Opinion in HIV and AIDS·Guadalupe AndreaniMichel J Tremblay

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.